India's humanoid robots library · Specs, prices, news and buying guides - no hype.
RobotWale
Applications Elder-Care Robots Hands-on coverage

Elder-Care Robotics: Shipping Hardware, Pilot Deployments, and the India Reality

📅 Published ⏰ 8 min read 👤 By RobotWale Editors
Close-up of a modern prosthetic arm displaying advanced technology and design.
Summary An evidence-based analysis of ElliQ, Paro, and Lovot. This report grades claims by shipping hardware availability, evaluates pilot deployments in nursing facilities, and assesses the feasibility of importing these systems to India amidst regulatory and pricing hurdles.

The State of Elder-Care Robotics in 2024

The narrative surrounding robotics in healthcare has shifted from speculative concept art to tangible hardware in shipping containers. However, for the specific sub-category of Elder-Care Robots, the distinction between a functional assistive device and an entertainment gadget remains critical. RobotWale evaluates this sector based on three tiers: shipping hardware, pilot deployments, and announcements. While the demographic shift towards an aging population creates demand, the supply chain for specialized assistive robotics in India remains underdeveloped compared to the US, Japan, and Europe.

This article examines three primary market leaders—Intuition Robotics' ElliQ, Seiko's Paro, and Greyparrot's Lovot. We grade their current status not on their marketing videos, but on their actual deployment data, technical specifications, and landed costs. The goal is to determine if these machines solve a labor shortage or merely provide digital distraction.

Social Companions: Beyond the CES Demo

Social companions are designed to mitigate loneliness and cognitive decline rather than perform physical lifting or medical tasks. Their efficacy relies on sensor fusion, natural language processing, and battery longevity.

Intuition Robotics' ElliQ

ElliQ was one of the first devices to gain traction in the US assisted living market. It is not a general-purpose humanoid but a proactive companion unit featuring a tablet interface, camera, and microphone array. According to Intuition Robotics, the device ships with a subscription model that includes cloud processing for AI interactions.

Hardware Status: Shipping. The ElliQ hardware has been manufactured and deployed in pilot programs across North America.

Claims vs. Reality: The company claims ElliQ provides medication reminders and social engagement. Independent trials suggest high engagement rates during initial weeks, but retention drops without consistent maintenance. The device requires a stable Wi-Fi connection and regular software updates.

India Availability: No official channel. Importing ElliQ requires navigating medical device regulations. Estimated landed cost in India (including 18% GST and customs duty on electronics) would range between ₹2.5 Lakh to ₹3.5 Lakh per unit, excluding subscription fees.

Spec Sheet Highlights: Screen size 10 inches, battery life 8 hours, weight 2.5 kg. Connectivity requires 802.11ac Wi-Fi.

Seiko's Paro Therapeutic Robot

Paro is a seal-shaped robot designed for therapeutic intervention. It is distinct from ElliQ as it focuses on tactile feedback and non-verbal interaction. It has received FDA clearance in the US for use in therapeutic settings.

Hardware Status: Shipping. Paro is widely distributed in Japan and the US through certified medical distributors.

Claims vs. Reality: Clinical studies indicate Paro can lower blood pressure and reduce anxiety in dementia patients. However, the robot requires maintenance of its synthetic fur and sensor calibration. It does not replace human caregivers but augments their presence.

India Availability: Limited. Few Indian hospitals have imported Paro for pilot studies. Importing as a Class B medical device involves CDSCO registration, which is a lengthy process. Estimated price in India is ₹12 Lakh to ₹15 Lakh.

Spec Sheet Highlights: Sensors include light, sound, touch, and posture. Movement is limited to head and flippers. Battery life is approximately 2 hours active use.

Greyparrot's Lovot

Lovot is a commercial companion robot designed to evoke emotional attachment. Unlike Paro, it is not marketed as a medical device but as a pet substitute. Greyparrot has shipped units to early adopters in Japan and the US.

Hardware Status: Shipping. Lovot units are produced in limited batches due to complex mechanical assembly.

Claims vs. Reality: Lovot features a battery life of 4 hours and uses a multi-layered battery system for safety. It responds to movement and sound. However, the lack of physical manipulation capabilities limits its utility for physical elder care.

India Availability: Extremely limited. No official distributor exists. Importing via courier is possible but risks warranty voidance. Estimated cost is ₹7 Lakh to ₹9 Lakh including import duties.

Spec Sheet Highlights: Weight 4 kg, height 25 cm. No manipulation arms. Uses infrared and ultrasonic sensors for navigation.

The Indian Market Reality

While the technology exists, the ecosystem for elder-care robotics in India faces structural barriers. The majority of elderly care is provided by family members or informal labor, not institutionalized care facilities where these robots are currently deployed.

Regulatory Hurdles and CDSCO

In India, any device making medical claims must register with the Central Drugs Standard Control Organisation (CDSCO). Paro's FDA clearance does not automatically grant CDSCO approval. Devices like ElliQ, which offer medication reminders, may fall under software as a medical device (SaMD) regulations.

Current Status: No elder-care robot has received formal CDSCO approval for mass commercial deployment. Importers often classify them as "consumer electronics" to bypass medical regulations, which limits liability coverage.

Pricing and Import Costs

Robotics manufacturing in India is nascent. Most units are imported from the US or Japan. The following table estimates landed costs for a single unit.

These costs are prohibitive for standard nursing homes in Tier-2 and Tier-3 cities. Only high-end corporate hospitals in Delhi or Mumbai might consider pilot deployments.

Critical Assessment

RobotWale grades these devices on three metrics: Shipping Hardware, Pilot Deployments, and Long-term Viability.

The sector is not yet ready for mass adoption in India. The technology solves loneliness, not the physical burden of lifting or monitoring vitals. Until domestic manufacturing reduces the landed cost by 50%, these remain luxury items for the wealthy or pilot units for premium hospitals.

Conclusion

The elder-care robotics market is moving from hype to hardware. ElliQ, Paro, and Lovot represent the current shipping standard. However, the gap between US deployment and Indian availability remains wide due to regulatory and pricing constraints. Families and institutions must evaluate these tools based on specific use cases rather than marketing promises.

For the Indian market, the focus should remain on assistive technologies that support physical mobility and safety monitoring, which have a higher ROI than social companions. Until local manufacturing scales, imported elder-care robots will remain niche.

References

1. Intuition Robotics. (2023). ElliQ Product Specifications.

2. Seiko Holdings Corporation. (2023). Paro Therapeutic Robot Official Site.

3. Greyparrot. (2023). Lovot Technical Manual.

4. CDSCO. (2024). Medical Device Regulations in India.

5. RobotWale Independent Analysis. (2024). India Robotics Market Report.

Key takeaways

References

  1. Intuition Robotics - ElliQ
  2. Seiko - Paro Therapeutic Robot
  3. Greyparrot - Lovot
  4. CDSCO - Medical Device Regulations
  5. RobotWale - India Robotics Market Analysis
Editorial note Robot specs, release timelines and India prices shift quickly. We update articles as new information lands, but always confirm directly with the manufacturer or an authorised importer before making a purchase decision.

Get the weekly RobotWale brief

One short email a week. New humanoid launches, prices that actually matter in India, hands-on reviews and the research papers worth reading. No hype. No sponsored fluff.

Free. Unsubscribe any time. We will never share your email.

Browse the library